Interferon alpha 2b: Chinese guidelines for COVID-19 have used 5 million IU IFN-α 2b, twice per day, nebulized in 2mL sterile water. https://t.co/4J1XNvK4ko https://t.co/H5UAyU4sde https://t.co/F0FFg625id https://t.co/g6j2kRe8VE https://t.co/vlPswac11E
Drug treatment options for the 2019-new coronavirus (2019-nCoV).
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2020 – Apr 2022Where it's discussed
-
X / Twitter30 posts
-
News3 articles
-
YouTube2 videos
-
Facebook2 posts
-
Reddit2 posts
-
Blogs2 articles
AI synopsis
What people are saying
Discussions express strong interest and support for the article through references to specific treatments such as interferon alpha 2b and ongoing trials, with tone and word choices like 'many trials' and 'update needed' emphasizing their engagement. The comments suggest that the article influences ongoing clinical evaluations and public understanding of potential COVID-19 therapies.
Most discussions acknowledge the importance of exploring drug treatment options and reference specific treatments like interferons, indicating general agreement with the article’s focus.
Posts demonstrate high curiosity about ongoing trials and specific therapies, showing strong engagement with new developments.
Participants comment on trial updates and question the efficacy of treatments, reflecting active discussions and deeper consideration.
The conversations highlight the significance of the article's content for informing clinical responses and treatment strategies during the outbreak.
Abstract in brief
- As of January 22, 2020, there were 571 reported cases of 2019-nCoV in China, and since there is no existing vaccine or antiviral treatment, finding effective drug options is urgent.
- Researchers are exploring three main approaches: using broad-spectrum antivirals, screening chemical libraries for potential compounds, and developing new drugs based on the virus's genetic information.
- Several potential treatments are being considered, including antiviral drugs like Lopinavir Ritonavir and Remdesivir, traditional Chinese medicines, and anti-inflammatory agents, but their safety and effectiveness need further clinical testing.]
Top posts
Most liked on X and BlueskyInteresting article "Drug treatment options for the 2019-new coronavirus (2019-nCoV)" (via #pubmedontap) https://t.co/uULFeHu4XQ
この記事激アツだから各位読んでほしい Drug treatment options for the 2019-new coronavirus (2019-nCoV) https://t.co/w5FxS4evK4
Drug treatment options for the 2019-new #coronavirus (2019-nCoV) https://t.co/xIpTlr4ZUz
RT @__ice9: Interferon alpha 2b: Chinese guidelines for COVID-19 have used 5 million IU IFN-α 2b, twice per day, nebulized in 2mL sterile…
RT @__ice9: Interferon alpha 2b: Chinese guidelines for COVID-19 have used 5 million IU IFN-α 2b, twice per day, nebulized in 2mL sterile…
All mentions
Understanding the 2020 Wuhan Pneumonia Outbreak and Its Impact
This video presents a historical overview of the pneumonia outbreak of unknown etiology that emerged in Wuhan, China. It emphasizes the urgency as health officials sought to identify the pathogen and details the global…
Hydroxychloroquine in COVID-19: Efficacy and Risks Explained
This video discusses Hydroxychloroquine's role in COVID-19 treatment and prevention, highlighting its mechanism of action and the mixed results from various studies. It addresses concerns regarding side effects and…
RT @__ice9: Interferon alpha 2b: Chinese guidelines for COVID-19 have used 5 million IU IFN-α 2b, twice per day, nebulized in 2mL sterile…
RT @__ice9: Interferon alpha 2b: Chinese guidelines for COVID-19 have used 5 million IU IFN-α 2b, twice per day, nebulized in 2mL sterile…
RT @__ice9: Interferon alpha 2b: Chinese guidelines for COVID-19 have used 5 million IU IFN-α 2b, twice per day, nebulized in 2mL sterile…
RT @__ice9: Interferon alpha 2b: Chinese guidelines for COVID-19 have used 5 million IU IFN-α 2b, twice per day, nebulized in 2mL sterile…
RT @__ice9: Interferon alpha 2b: Chinese guidelines for COVID-19 have used 5 million IU IFN-α 2b, twice per day, nebulized in 2mL sterile…
Interferon alpha 2b: Chinese guidelines for COVID-19 have used 5 million IU IFN-α 2b, twice per day, nebulized in 2mL sterile water. https://t.co/4J1XNvK4ko https://t.co/H5UAyU4sde https://t.co/F0FFg625id https://t.co/g6j2kRe8VE https://t.co/vlPswac11E
Drug treatment options for the 2019-new coronavirus (2019-nCoV). https://t.co/rE06SAtFDA
@Stevens_AK There have been many trials. The Podcast needs to be updated. 571 patients https://t.co/DYvOIBuBdh https://t.co/HnXAC7g2Ck
Para médicos y especialistas. Drug treatment options for the 2019-new coronavirus (2019-nCoV) https://t.co/69tYEzyBee
Core Pubmed: Drug treatment options for the 2019-new coronavirus (2019-nCoV).: Related Articles Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020 Mar 16;14(1):69-71 Authors: Lu H… https://t.co/q89mnPn8Vc #coronavirus #SARS_CoV_2 #covid19
Drug treatment options for the 2019-new coronavirus (2019-nCoV). - PubMed - NCBI https://t.co/HAF2AyvfLQ
Drug treatment options for the 2019-new coronavirus (2019-nCoV) https://t.co/JATTjSLDXL
この記事激アツだから各位読んでほしい Drug treatment options for the 2019-new coronavirus (2019-nCoV) https://t.co/w5FxS4evK4
#Drug #treatment options for the 2019-new #coronavirus (2019-nCoV). https://t.co/ftlUnlpH10 from @QxMD #CoV19 #COVIDー19
Drug treatment options for the 2019-new coronavirus (2019-nCoV) https://t.co/DVTPdSPXnP
Drug treatment options for the 2019-new #coronavirus (2019-nCoV) https://t.co/xIpTlr4ZUz
コロナウイルス、治療に新たな進展ですか Drug treatment options for the 2019-new coronavirus (2019-nCoV). - PubMed - NCBI https://t.co/DTmFZcMHzU
Drug treatment options for the 2019-new coronavirus (2019-nCoV). - PubMed - NCBI https://t.co/lHlnBqEFo6
Trend up+3: *Lu H* (Biosci Trends) __Drug treatment options for the 2019-new coronavirus (2019-nCoV)__ https://t.co/I2Br48pKHT
Drug treatment options for the 2019-new coronavirus (2019-nCoV). https://t.co/Jmixcmrn5h
RT @randymd: Interesting article "Drug treatment options for the 2019-new coronavirus (2019-nCoV)" (via #pubmedontap) https://t.co/uULFeHu4…
RT @randymd: Interesting article "Drug treatment options for the 2019-new coronavirus (2019-nCoV)" (via #pubmedontap) https://t.co/uULFeHu4…
Interesting article "Drug treatment options for the 2019-new coronavirus (2019-nCoV)" (via #pubmedontap) https://t.co/uULFeHu4XQ
Trend up+1: *Lu H* (Biosci Trends) __Drug treatment options for the 2019-new coronavirus (2019-nCoV)__ https://t.co/I2Br48pKHT
Trend new: *Lu H* (Biosci Trends) __Drug treatment options for the 2019-new coronavirus (2019-nCoV)__ https://t.co/I2Br48pKHT
Trend up+2: *Lu H* (Biosci Trends) __Drug treatment options for the 2019-new coronavirus (2019-nCoV)__ https://t.co/I2Br48pKHT
Trend up+6: *Lu H* (Biosci Trends) __Drug treatment options for the 2019-new coronavirus (2019-nCoV)__ https://t.co/I2Br48pKHT
Trend up+9: *Lu H* (Biosci Trends) __Drug treatment options for the 2019-new coronavirus (2019-nCoV)__ https://t.co/I2Br48pKHT
Trend new: *Lu H* (Biosci Trends) __Drug treatment options for the 2019-new coronavirus (2019-nCoV)__ https://t.co/I2Br48pKHT